Screening for prostate cancer: A survey of New Zealand general practitioners

New Zealand Medical Journal

Volumn 116, Issue 1176, 2003, Pages

  Durham, John ^a,b   Low, Melissa ^a   McLeod, Deborah ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Ora Toa Medical Centre   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FAMILIAL CANCER; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; LIFE EXPECTANCY; MALE; NEW ZEALAND; PHYSICIAN ATTITUDE; PROFESSIONAL PRACTICE; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SURVIVAL TIME; URBAN AREA; ADULT; AGED; BLOOD; CLINICAL PRACTICE; FEMALE; GENERAL PRACTICE; MASS SCREENING; MIDDLE AGED; PHYSICAL EXAMINATION; PROSTATE TUMOR; STATISTICS;

ADULT; AGED; FAMILY PRACTICE; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MASS SCREENING; MIDDLE AGED; NEW ZEALAND; PHYSICAL EXAMINATION; PHYSICIAN'S PRACTICE PATTERNS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 0038013965     PISSN: 11758716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. New Zealand Health Information Service. Cancer: new registrations and deaths 1999. Wellington: New Zealand Health Information Service; 2003. URL: http://www.nzhis.govt.nz/publications/Cancer.html Accessed June 2003.
2. New Zealand Health Information Service. Mortality and demographic data 1999. Wellington: New Zealand Health Information Service; 2003. URL: http://www.nzhis.govt.nz/publications/Mortality.html Accessed June 2003.
3. Beaglehole R, Bonita R, Kjellstrom T. Basic Epidemiology. Geneva: The World Health Organization; 1993.
4. National Health Committee. Screening for prostate cancer. Fifth Annual Report, Personal Health Services. Wellington: National Health Committee; 1996. URL: http://www.nhc.govt.nz/publications/annual5/prostate.html Accessed June 2003.
5. Morris J, McNoe B. Screening for prostate cancer: what do general practitioners think? NZ Med J 1997;110:178-82.
6. Voss JD, Schectman JM. Prostate cancer screening practices and beliefs. J Gen Intern Med 2001;16:831-7.
7. Fowler FJ Jr, Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med 1998;104:526-32.
8. US Preventive Service Task Force. Guide to clinical preventive services. 2nd edition. Washington, DC: US Department of Health and Human Services; 1996.
9. Durham J. Population screening for prostate cancer. A systematic review. Wellington: New Zealand Guideline Group; 2002. URL: http://www.nzgg.org.nz/development/documents/Prostate_Cancer_review.pdf Accessed June 2003.
10. Girgis S, Ward JE, Thomson CJH. General practitioners' perceptions of medicolegal risk. Using case scenarios to assess the potential impact of prostate cancer screening guidelines. Med J Aust 1999;171:362-6.
11. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781-9.
12. Hoffman RM, Clanon DL, Littenberg B, et al. Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels. J Gen Intern Med 2000;15:739-48.
13. Pickens GJ, Roehrborn CG. Variability of repeated prostate specific antigen measurements within less than 90 days in a well-defined patient population. Proc Am Urol Assoc 1995;153:936A.